Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection continues to spread in a wave-like manner globally amidst a limited supply of the COVID-19 vaccine and is accompanied by an established high mortality risk in kidney transplant recipients (KTR)1 which has led to this population being prioritized as one of the groups to be vaccinated in the first phase.
SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients.